Biocartesian combines microscopy and chemistries to detect molecules in tissues, providing insights into disease biology and therapies.
Biocartesian has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2024.
Biocartesian's investors include Y Combinator.
Biocartesian is headquartered in San Francisco, United States.
Biocartesian combines microscopy and chemistries to detect molecules in tissues, providing insights into disease biology and therapies.
Biocartesian is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biocartesian — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/biocartesian. Accessed August 1, 2026.
VCBacked. (2024). Biocartesian — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/biocartesian
{{cite web |title=Biocartesian — Funding & Investors |url=https://www.vcbacked.co/company/biocartesian |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated